BMI, commonly used to define obesity, has been used for “racist exclusion” and h...
In the latest edition of STAT's Health Tech newsletter: Suicide hotlines shared ...
Why did you overdose today, of all days? This question inspired a novel study ab...
Sen. Bernie Sanders wants the NIH to adopt "reasonable pricing" protocols for dr...
“It is tragic to see that young people with opioid use disorder are unable to ac...
Moving past regulatory obstacles, Protagonist Therapeutics looks to pivotal tria...
Biogen said that its longtime and polarizing director Alex Denner would step dow...
Biotech executive nominated to Biogen board is mother of director's child, recor...
Suicide hotlines promise anonymity. Dozens of their websites send sensitive data...
Kura faces competition in the menin inhibitor market as the therapy is being dev...
Two broad health reform initiatives are affected by the election.
ViXome showed potent immunomodulatory and pro-reparative effects in pre-clinical...
The NDA submission was based on the findings of the CAPItello-291 Phase III trial.
Syncona launches its third gene therapy company to stake a claim in the ophthalm...
Following a December approval, the FDA has now given Ferring Pharmaceuticals cle...
The activators might represent both an outpatient, oral therapy for chronic hear...
